Furthermore, we found that lipophilic statins, including simvastatin, fluvastatin, mevastatin, and lovastatin, exhibited potent inhibitory effects on PTTG1 expression in metastatic MD-MBA-231 breast cancer cells, while hydrophilic pravastatin had no effect. Here, PTTG1 is linked to breast cancer.